In this file
A live appointment can make it easier to discuss a complex treatment history or ask follow-up questions. The important details are who attends, when appointments occur, and whether later visits are included.
CoreAge Rx is the first commercial reference, but we have not confirmed a scheduled video visit for every patient. Other entries describe specific video arrangements that should still be checked for the selected pathway.
How to use this shortlist
CoreAge Rx is listed first under a commercial partnership. The first position is predetermined by that relationship, and links may earn compensation. It is not an independent finding that CoreAge has the safest medicine, the lowest total price, or the strongest patient outcomes.
Ask for the prescribing clinician’s visit format and schedule. We compare public care descriptions and payment terms. We have not purchased treatment, audited every professional license, or timed the support response. Use the linked source notes and obtain a current personal quote.
01. CoreAge Rx · sponsored first position
This is the paid featured reference for the question in this guide. Its placement does not establish that every feature discussed here is available through its program. Ask about the exact product and care access before assuming a match.
CoreAge Rx provides an online route to medical assessment and, where a clinician prescribes, pharmacy fulfillment. The service is our paid featured partner. That commercial relationship buys its prominent position here; it does not establish a better medicine, a better outcome, or suitability for any particular reader.
The current starting equivalents are $79 for semaglutide and $129 for tirzepatide on 12-month plans, without a separate membership charge. Those plans total $948 and $1,548 respectively; one-month prices are $139 and $199. A reader should obtain the duration and total for the selected prescription rather than assuming that the smaller figure is charged monthly.
A question to put to the provider: Can you send the full payment schedule and the name of my dispensing pharmacy before I accept the offer?
Read the CoreAge Rx provider file and cost explanation for the connected details.
2. SuperHealthy Rx — GLP-1 care
SuperHealthy Rx advertises compounded semaglutide from $85/month and tirzepatide from $135/month. The linked offer says the provider visit and shipping are included. Confirm the amount due, plan term and refill settings; a prescription depends on clinician review. These are published service terms, not independently tested outcomes. Current offer.
3. Likeness Rx — GLP-1 weight care
The product name is a starting point for a care conversation. Likeness Rx offers online access to compounded semaglutide and tirzepatide. Its public page lists semaglutide from $79/month; tirzepatide from $129/month.
The lowest monthly equivalents accompany 12-month subscriptions: $948 for semaglutide or $1,548 for tirzepatide. One-month plans are $139 and $199. The page says the selected term renews automatically; check the amount due and cancellation date.
The public site describes licensed-provider review, shipping after approval and care-team messaging. Those are service statements rather than measured response times.
These are provider-published terms checked October 4, 2026. Prescription approval is conditional. Compounded medications are not FDA-approved; we have not tested the treatment, pharmacy fulfillment or patient outcomes.
Product and subscription information checked at likenessrx.com on October 4, 2026.
4. Shapely
The comparison point for Shapely: Scheduled provider contact and dietitian access need to be priced alongside the medicine.
Shapely describes monthly video visits, nutrition-professional access, and help with insurance and pharmacy coordination. Its self-pay and insured arrangements should be compared as separate care pathways.
The advertised self-pay membership begins at $49 for the first month and $99 thereafter. Medication is not included, and laboratory charges may apply. An insured visit does not by itself establish a covered weight-loss prescription.
A question to put to the provider: Which provider and dietitian appointments are included in my selected pathway, and what remains payable separately?
The Shapely alternatives guide examines this arrangement in more detail. You can also consult the official provider page.
5. Calibrate
The comparison point for Calibrate: The membership pays for a structured program while labs and medicine remain separate.
Calibrate describes a clinician video appointment, individual coaching by video, and a curriculum. Insurance navigation is part of the service, but an authorization decision remains with the insurer.
Membership is listed at $199 monthly with an initial three-month obligation of $597 paid in installments. Medication and laboratory testing are excluded. A low drug copay example is not the complete cost of that commitment.
A question to put to the provider: What will I owe for the first three months if medication coverage is unavailable?
The Calibrate alternatives guide examines this arrangement in more detail. You can also consult the official provider page.
6. Sesame Care
The comparison point for Sesame Care: The lowest care equivalent requires a longer commitment and excludes medication.
Success by Sesame describes recurring video appointments, clinician messaging, and an ongoing provider relationship. Confirm that the selected subscription includes the visit cadence you want.
The care offer starts at $59 per month on a twelve-month commitment, compared with a $99 month-to-month option. Medication is separate. Cancellation conditions distinguish the period before the initial appointment from the period afterward.
A question to put to the provider: What is the full care obligation after the first appointment, and what will the chosen pharmacy charge?
Use the official Sesame Care page to request the current plan and conditions.
7. PlushCare
The comparison point for PlushCare: Membership, appointments, tests, and medicine are separately identifiable costs.
PlushCare uses a primary-care video-visit model and describes prior-authorization help when appropriate. Insurance is accepted but not required, and the cost depends on the patient’s own plan.
Published figures include a $19.99 monthly membership after the introductory free month and a $129 uninsured initial appointment. Prescriptions and laboratory testing are additional; insured appointment costs depend on coverage.
A question to put to the provider: What will a follow-up appointment cost, and does my insurer cover the specific drug as well as the visit?
Use the official PlushCare page to request the current plan and conditions.
8. Found
The comparison point for Found: Insurance and cash-pay pathways use different visit formats and cost components.
Found’s pricing explanation distinguishes video visits on the insurance pathway from cash-pay care generally conducted through text. It also describes medication inclusion differently for compounded and branded prescriptions.
The page advertises $99 insurance-pathway and $169 cash-pay equivalents on twelve-month prepaid plans, alongside 28-day billing language. Published monthly figures are $199 and $289 respectively. Copays and branded drug bills can remain additional.
A question to put to the provider: How many 28-day periods does the quoted term cover, and what will visits and medication add?
The Found alternatives guide examines this arrangement in more detail. You can also consult the official provider page.
Make the decision concrete
Bring these three checks to the shortlist. If an answer describes another product, a different payment period, or a service you are not eligible for, the comparison is not finished.
- Ask for the prescribing clinician’s visit format and schedule.
- Separate coaching, support calls, and prescribing appointments.
- Discuss accessibility needs and any extra appointment charge before joining.
Separate the product from the provider
FDA approval belongs to a particular drug product, not to a review site’s list or a telehealth brand. A compounded preparation has not received that approval. Ingredient similarity does not establish the same route, formulation, manufacturing controls, or evidence.
Ask the clinician why the exact prescription fits your medical needs. Then ask the pharmacy for the label and instructions appropriate to that product. Read what compounding and FDA approval mean if those terms are being used interchangeably in a promotion.
Before accepting another offer
Keep the current agreement, prescription label, and any pending order information together. A new enrollment does not automatically stop the previous company’s next charge or authorize a continuation prescription.
Use the questions-before-purchase checklist to record the answers in your own words. A useful next step is a clear conversation and a complete proposal, not a decision based on a rank alone.
Source notes
Provider material describes the company’s own offer. Official medical references explain clinical and regulatory context; they do not endorse this publication or its commercial partner.
- CoreAge Rx: official treatment overview ↗Provider-published information · Checked September 22, 2026
- CoreAge Rx: current sale offer ↗Provider-published information · Checked September 22, 2026
- CoreAge Rx: plan billing explained ↗Provider-published information · Checked September 22, 2026
- CoreAge Rx: contact and professional-entity disclosures ↗Provider-published information · Checked September 22, 2026
- CoreAge Rx: purchasing process ↗Provider-published information · Checked September 22, 2026
- Shapely: official program, pricing, and care details ↗Provider-published information · Checked September 22, 2026
- Calibrate: official program, pricing, and care details ↗Provider-published information · Checked September 22, 2026
- Sesame Care: official program, pricing, and care details ↗Provider-published information · Checked September 22, 2026
- PlushCare: official program, pricing, and care details ↗Provider-published information · Checked September 22, 2026
- Found: official program, pricing, and care details ↗Provider-published information · Checked September 22, 2026
- FDA: concerns with unapproved GLP-1 drugs ↗Regulatory / public agency · Checked September 22, 2026
- FDA: risks of compounded drugs ↗Regulatory / public agency · Checked September 22, 2026
- Likeness Rx — GLP-1 weight care ↗Provider-published information · Checked 2026-10-04